Internet Archive Scholar

Rizzo_et_al_Revised_Supplementary_material – Supplemental material for Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis

Alessandro Rizzo, Margherita Nannini, Marco Novelli, Angela Dalia Ricci, Valerio Di Scioscio, Maria Abbondanza Pantaleo
2020 Figshare  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (150.8 kB)
https://web.archive.org/web/20200717013145/https://s3-eu-west-1.amazonaws.com/pstorage-sage-1076303800/23742594/Rizzo_et_al_Revised_Supplementary_material.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Supplemental material, Rizzo_et_al_Revised_Supplementary_material for Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis by Alessandro Rizzo, Margherita Nannini, Marco Novelli, Angela Dalia Ricci, Valerio Di Scioscio and Maria Abbondanza Pantaleo in Therapeutic Advances in Medical Oncology
doi:10.25384/sage.12624492 fatcat:urlkhed4wbbotng2tb3a62ywwe
Open Access
Citation

Alessandro Rizzo, Margherita Nannini, Marco Novelli, Angela Dalia Ricci, Valerio Di Scioscio, Maria Abbondanza Pantaleo. "Rizzo_et_al_Revised_Supplementary_material – Supplemental material for Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis." Figshare (2020)